A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson’s DiseaseMilton H. Werner, Aaron Ellenbogen, Andrew McGarry et al.|Journal of Parkinson s Disease|2024Cited by 7